Bradycardic Syncope in 2 Patients Who Recently Began Gatifloxacin Treatment | Zendy

W. J. Nicholson | Zendy; Alfred E. Buxton | Zendy; Dominick Tammaro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bradycardic Syncope in 2 Patients Who Recently Began Gatifloxacin Treatment

Author(s) -

W. J. Nicholson,

Alfred E. Buxton,

Dominick Tammaro

Publication year - 2003

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/344790

Subject(s) - gatifloxacin , medicine , bradycardia , food and drug administration , syncope (phonology) , anesthesia , antibiotics , cardiology , pharmacology , heart rate , blood pressure , levofloxacin , microbiology and biotechnology , biology

Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone approved by the United States Food and Drug Administration in December 1999. Few side effects of this new antibiotic have been reported, and there are no previous case reports of bradyarrhythmias. We report 2 cases of syncope due to bradycardia in patients who recently began treatment with gatifloxacin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research